Office of Research & Development |
|
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01CX001547-01A2 |
| Title: | Preventing levodopa induced dyskinesia in Parkinsons Disease with Statins |
| Principal Investigator: | Kathryn A. Chung |
| Location: | Portland, OR |
| Congressional District Code: | 3 |
| Research Service: | Clinical Science R&D |
| Project Period: | April 2019 - March 2023 |
| FY 2021 Funding Amount: | $152,839 |
| Total Award Amount (all years): |
$599,359 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: The purpose of this project is to determine whether HMG-CoA reductase inhibitors (statins) will inhibit the progression of levodopa (LD) induced dyskinesia in Parkinson disease (PD) given that rodent and primate models have carefully demonstrated this. LD is the most important medication that Veterans with PD will take to control their symptoms and has remained so since its discovery in the 1960s. Unfortunately, early recognition of the benefits of LD against the stiffness, slowness and tremor o... |